Amicus Curiae Brief — Warner-Jenkinson Co. v. Hilton Davis Chemical Co.
Supreme Court brief1997
Ask Donna
What actually matters in this document.
Text
Q
(
No. 95-728 aan
IN THE
Supreme Court of the Gnited States
OCTOBER TERM, 1995
WARNER-JENKINSON COMPANY, INC.,
Petitioner,
v.
HILTON DAVIS CHEMICAL Co.,
Respondent.
On Writ of Certiorari to the
United States Court of Appeals
for the Federal Circuit
BRIEF OF GATEWAY TECHNOLOGIES, INC.,
AS AMICUS CURIAE IN SUPPORT OF PETITIONER
RICHARD GRANT LYON, Esq.
Counsel of Record
GIBSON, DUNN & CRUTCHER
1717 Main Street
Suite 5400
Dallas, Texas 75201
(214) 698-3100
Attorney for Amicus Curiae
PRESS OF BYRON S. ADAMS, WASHINGTON, D.C. 1-800-347-8208
ee
Statutes and Miscellaneous
TABLE OF AUTHORITIES
35 U.S.C. § 112, 42....ceeeeneereneeeerennernneescnnnneerseees
Cases
— 3S U.S.C. § 251....ccseeeceeeserenceeeernnsesenenssennnssereees
Brenner v. United States, 773 F.2d 306 (Fed.Cir. ; —
aa esciitia iis a cllisiisessepscecnees 9 Fed. B. Civ. P. 4D -n.0enrorevonrererenersorersororsoverers
Graver Tank & Mfg. Co. v. Linde Air Products Fed. R. Civ. P. 50 .....ccecceeceeeeersenenennsensenennrsecers
Co., 339 U.S. GOS (1950) .....csccsccccccccccscres passim
Hilton Davis Chemical Co. v. Warner-Jenkinson
Co., 62 F.3d 1512 (1995) (en banc) ............. passim
Keystone Bridge Co. v. Phoenix Iron Co., 95 U.S.
EES TR 5 EE 7
Lear Siegler, Inc. v. Sealy Mattress Co. of
Michigan, Inc., 873 F.2d. 1422 (Fed. Cir.
ESE AS ey ee 11
Sanitary Refrigerator Co. v. Winters, 280 U.S. 30
Tistdhditintididabebndddinanbettichessenerescococecoces 8
Spectra Corp. v. Lutz, 839 F.2d 1579 (Fed.Cir.
SU Aiiidiiniehtindiessineenasiubennieesastenesesecoscecee 11
SUIT niduaibendndesdsnesscewsesseqceenensssesecceveccscccocees 6
Zenith Laboratories, Inc. v. Bristol-Myers Squibb
Co., 19 F.3d 1418 (Fed.Cir.), cert. denied,
U.S. ES ra 2
INTEREST OF AMICUS
Gateway Technologies, Inc., is a privately held company!
that has developed, manufactures, and sells a
telecommunication system that is based upon a patented
invention to the corrections market. As a
telecommunications niche supplier, patent protection and
research and development are crucial to its success. It is
currently involved in patent litigation as both plaintiff and
defendant. Amicus has a keen and immediate interest in the
role of the doctrine of equivalents in patent litigation.2
SUMMARY OF ARGUMENT
This case gives the Court the opportunity to reexamine
completely the applicability and scope of the doctrine of
equivalents. In the more than forty-five years since the
Court’s last explication of the doctrine, in Graver Tank &
Mfg. Co. v. Linde Air Products Co., 339 U.S. 605 (1950),
patent litigation has grown exponentially in volume,
complexity, and importance. Misuse of the doctrine of
equivalents has contributed to this growth. Patentee
plaintiffs have added charges of infringement by
equivalents as a matter of routine, making the doctrine the
"second prong” of virtually any infringement claim. This
expansive use of a judicially created doctrine intended by
this Court strictly as a means to avoid “piracy” and
1 Gateway has no subsidiaries.
2 Gateway has no financial or other direct interest in the
outcome of this case. Consents of the parties to this brief have
been filed with the Clerk.
3 Sen insite Mitetet Os « Cpietines Gn. 62
F.3d 1512, 1537 (Plager, J., dissenting); see also Pet. at 16
n. 16.
2
mindless formalism has brought consequences that do
violence to a basic principle of the patent system, the
notion that the patent claims define the metes and bounds of
the monopoly grant of a patent.4
The consequences to companies and individuals whose
livelihood depends upon invention are equally obvious and
“designing around" a patent as praiseworthy and a benefit
to society from the disclosure of an invention required to
obtain a patent monopoly. That healthy activity is
jeopardized by the threat of defending a new product
against an infringement claim based upon a general charge
of infringement by equivalents. As demonstrated by the
facts of this case, even the result of independent
development, with no copying at all, can be subject to an
injunction under such an indefinite standard.
It is high time, therefore, that this Court restores the
doctrine to its proper, limited place in patent litigation.
The Federal Circuit felt itself constrained from a
comprehensive reassessment of the doctrine by this Court’s
decision in Graver Tank. Having agreed to review the
Federal Circuit’s decision, this Court can and should
provide that reassessment in light not only of this Court’s
precedent, but also the practicalities of today’s patent
litigation and the policies of the Patent Act.
equivalents may be applied; and (ii) to list the factors that
4 See 35 U.S.C. § 112, 42; Zenith Laboratories, Inc. v.
Bristol-Myers Squibb Co., 19 F.3d 1418, 1430 (Fed.Cir.), cert.
denied, U.S.___ (1994).
3
to wht count end jury’ choi consider 2 mips
infringement by equivalents in such cases. _ Court
should provide a clear admonition to trial judges strictly to
control the circumstances in which infringement by
equivalence may be found.
STATEMENT OF THE CASE AND
FACTS
The facts underlying the infringement dispute in this
lawsuit are accurately stated in the Petition. Amicus would
emphasize the following facts:
i) Petitioner developed iits filtration process
. independently of Respondent's patent, Respondent's
process, and Respondent’s development activities.
Petitioner began its research in 1982, more than
three years before the patent issued and four years
before it actually became aware of the patent.
There is no evidence that “copying” played any part
in Petitioner’s development or refinement of its
(ii) Petitioner’s process added significant value to the
approximately 6.0" without encountering the
foaming” that appeared to have limited the range
claimed in Respondent’s patent.
4
(iii) The difference between the pH used in Petitioner’s
process (5.0) was material from that claimed in the
patent (“approximately 6.0 to 9.0"). A change in
one numerical pH value “represents a relative
change in the acidity equal to a factor of 10," and
greater changes are even more substantial since the
pH scale is logarithmic. 62 F.3d at 1580 n.35
(Nies, J., dissenting).
Similarly, we emphasize certain aspects of the prior
proceedings in this litigation:
(i) This case went to the jury only on a claim of
infringement by equivalents. At trial Respondent
disclaimed its original charge of literal
infringement.
(ii) The Court of Appeals felt itself bound by this
Court’s Graver Tank decision. Indeed a dissenting
judge chided the majority for adhering to Graver
Tank rather than giving the doctrine of equivalents
an overhaul for this Court to evaluate. 62 F.3d at
1545 (Plager, J., dissenting).
(iii) All of the judges of the Federal Circuit who
participated in the en banc decision recognized the
need for the doctrine of equivalents against piracy
and the unscrupulous copier. The differences
among the judges went to the factors to be
considered in applying and undertaking an
equivalency analysis, and to whom—judge or
jury—should make the analysis.
(iv) Applying the doctrine of equivalents to a particular
case requires determination of underlying facts.
This was also the unanimous view of the judges of
the Federal Circuit.
5
ARGUMENT
L
THE DOCTRINE OF EQUIVALENTS
SHOULD BE LIMITED IN
APPLICATION TO PREVENT
"INVENTION" BY COPYING
The facts involved in Graver Tank support the view that
the doctrine of equivalents was intended to be, and should
be, carefully limited to prevention of “piracy” by an
“unscrupulous copyist"“—a so called “invention” that
consists primarily of manipulation, more of words than of
substance, around the literal scope of a valid patent claim.
At issue in Graver Tank was the trial court’s finding of
infringement by equivalents of Linde’s patent claims
covering an electric welding composition. The patented
invention and the alleged infringing composition were
“alike” in all respects except that the infringing product
used silicates of calcium and manganese rather than silicates
of calcium and magnesium. The patent claimed a flux
“containing a major proportion of alkaline earth metal
silicate.” Manganese is not an alkaline earth metal. 339
U.S. at 610. The trial judge found the two compositions
“substantially identical in operation and in result,” based
upon evidence including:
(1) Expert testimony that manganese and magnesium
were similar in many of their reactions (id. );
(2) Expert testimony that alkaline earth metals are often
found in manganese ores in their natural state that
they serve the same purpose in fluxes (id. at
610-11);
© Graver Tank, 339 U.S. at 607.
ae
6
(3) Contemporaneous prior art references that disclosed
use of manganese silicate in welding fluxes (id. at
611);
(4) The fact that "the record contains no evidence of
any kind to show that [the infringing product] was
developed as the result of independent research or
experiments” (id.).
On the basis of these findings, which the Court upheld as
not clearly erroneous, the Court concluded that “it is
difficult to conceive of a case more appropriate for
application of the doctrine of equivalents," and that:
"[w]ithout some explanation or indication
that [the infringing product] was developed
by independent research, the trial court
could properly infer that the accused flux is
the result of imitation rather than
experimentation or invention."
Id. at 612.
Since its origination by the courts’ the doctrine of
equivalents has been intended primarily if not exclusively to
prevent “fraud on a patent." That it has been taken far
beyond this limited purpose is beyond doubt. It has been
used, and was used in this case, to attempt to enlarge a
patent beyond limits specifically demarcated (in this case
numerically) in the applicable patent claim. It has been
used, and was used in this case, to attempt to circumvent
the doctrine of Patent Office or prosecution history
estoppel. It has been used, and was used in this case, to
7 The doctrine in this country dates back at least to this
Court’s decision in Winans v. Denmead, 56 U.S. (15 How.) 330
(1854). Several dissenting judges in the Federal Circuit trace its
genesis back to the English Court of Chancery. See, e.g., 62
F.3d at 1540-41 (Plager, J., dissenting).
7
enjoin further use of a product that was independently
developed and added material value to the invention
Claimed in the patent. Misuse of the doctrine, as in this
case, undermines the statutory requirement of clear
claiming in patent applications.* Such expansionist use of
this judicially created doctrine has cast uncertainty on the
innovation that is a crucial and necessary part of a
technology in other industries.
The pace of research and development and of the search
for new and better products is not likely to be retarded by
this uncertainty. Success in many marketplaces (certainly
those in which amicus competes) depends upon continual
technological advances and new and better products. What
this uncertainty unquestionably adds, though, is the cost
and risk of many unjustifiable lawsuits. In this case the
Court should make clear the limited applicability of the
doctrine of equivalents to cases in which copying, rather
than independent invention, is the principal issue.
IL
BY DIRECTING A DOCTRINE OF
EQUIVALENTS ANALYSIS TO
SPECIFIC FACTORS DESIGNED TO
DISTINGUISH COPYING FROM
INDEPENDENT DEVELOPMENT,
MANY EQUIVALENTS CASES CAN BE
RESOLVED EXPEDITIOUSLY
In Graver Tank, the Court enunciated what has come to
be known as the triple identity test: “a patentee may invoke
this doctrine to proceed against the producer of a device 'if
it performs substantially the same function in substantially
8 Post-issuance enlargement of claims is prohibited by the
Patent Act, 35 U.S.C. § 251, and forbidden to the courts in
patent litigation. Keystone Bridge Co. v. Phoenix Iron Co., 95
U.S. 274, 278 (1877).
the same way to obtain the same result.'" eae
citing Sanitary Refrigerator Co. v. Winters, 280 U.S. 30,
42 (1929). The Court listed the following factors as
relevant to conducting a function-way-result analysis:
(1) ". . . the purpose for which an ingredient is used in
a patent, the qualities is has when combined with the
other ingredients, and the function which it is
intended to perform" (339 U.S. at 609);
(2) Whether persons skilled in the art would have
known of the interchangeability of the ingredient
claimed to be equivalent (id.);
(3) Whether the accused product “was developed as a
result of independent research or experiments” (id.
at 611);
(4) Whether the accused product was “the result of
imitation rather than experimentation or invention"
(id. at 612);
(5) The degree to which the changes differed from those
claimed in the patent (id. ).
The Court of Appeals in this case focused on the first and
last of these factors, which it summarized as “the
icant Oe eee SO Pe ee
accused or ee 3d at .
also Sout a load then, and deemed relevant
evidence of whether the alleged infringer had knowingly
copied the patent in suit. The majority judges, however,
held that evidence of independent development (embodied
in the third and fourth factors listed above) was relevant
only to disprove a patentee’s evidence of copying by the
alleged infringer. The majority also rejected any evidence
of the intent of the alleged infringer. The dissenting judges
would have included both of these as relevant, and would
also have trial courts consider
9
(6) whether use of the doctrine is prohibited by the
rationale of prosecution history estoppel;
(7) prior art limitations; and
(8) whether the claim of infringement serves to enlarge
the patent claim.
Amicus would add a further factor, by rephrasing a
combination of items (1) and (5): whether the accused
product or process adds utility to the patented invention.
Amicus believes that all of the above factors, and perhaps
others, have their place, both in considering whether the
case is one of those few to which the doctrine of
equivalents may be applied, and, if so, in undertaking the
factual analysis? necessary to determine equivalency.
In many cases in which a patentee asserts infringement by
equivalence, careful control by the trial judge will permit
prompt resolution of these issues and simplification of the
matters ultimately to be determined by the fact finder.
Many factual matters, even in complicated lawsuits
involving complicated subject matter, are subject to
summary resolution by the trial court, "in a patent case as
in any other." Brenner v. United States, 773 F.2d 306,
307 (Fed. Cir. 1985). Amicus believes that many of the
doctrine of equivalents factors listed above will be
susceptible of such resolution in many of the cases in which
equivalency infringement is now asserted.
9 Two aspects of the doctrine of equivalents cited by this
Court in Graver Tank, 339 U.S. at 609, were acknowledged as
correct by all the judges of the Court of Appeals in this case:
——"Equivalence in the patent law, is not the prisoner of the
formula and is not an absolute to be considered in a
vacuum.”
-—"A finding of equivalents is a determination of fact."
—_—_—_—_—_—_— a ee ee. Ae
10
Trial courts can employ several of these criteria to
determine whether the doctrine is available at all. In our
view there is no place for the doctrine if the record reveals:
(i) significant independent development by the alleged
infringer, or
(ii) significant value added by the ingredient outside the
patent claim but alleged to be equivalent; or
(iii) claim of equivalence as to a matter which could
have been, but was not, claimed in the patent, or
which could not have been claimed in light of the
prior art. !0
Often sufficient evidence of one or more of these items
will be available early in a patent case; indeed (as in this
case), the patent prosecution history may disclose it. More
often, such evidence will be developed during discovery,
and available before trial for resolution by the Court on
summary judgment.
Other criteria relevant to an equivalence
analysis—substantiality of the differences in the two
products, the extent of copying versus designing around,
and the defendant’s intent—are less susceptible of bright
line rules, but may nevertheless be ruled on summarily by
the trial judge, either on a pretrial motion for summary
judgment or a post-verdict motion for judgment as a matter
of law (JMOL) under Fed. R. Civ. P. 50. Merely because
factual determinations are involved does not preclude
summary resolution if there is insufficient evidence to
present the fact finder with a material issue of fact for
determination. For example, the triple identity test is
conjunctive, and lack of evidence on any of its prongs will
10 As noted above, supra, pages 3-4, there was undisputed
evidence of all three of these criteria in this case.
oe
s oes
11
cause claimed equivalence to fail. There will be situations
where no reasonable juror could find substantial identity. !!
See, e.g., Spectra Corp. v. Lutz, 839 F.2d 1579, 1581-82
(Fed. Cir. 1988). In cases where a factual issue remains
for the jury a carefully crafted jury charge!2 and answers to
special interrogatories (Fed. R. Civ. P. 49) may yield a
factual foundation for a legal conclusion of JMOL.
For four distinct reasons, amicus prefers a summary
judgment standard to the equitable threshold test proposed
by the dissenting judges in the Court of Appeals. See 62
F.3d at 1544-45 (Plager, J., dissenting); 62 F.3d at 1549
(Lourie, J., dissenting). First, summary judgment is the
norm in all civil cases, and no one has advanced a
compelling reason why there should be a special rule, the
equivalent of an equitable writ, just for patent cases.
Second, the threshold test proposed by the dissenters turns,
as they acknowledge, not on traditional equitable
considerations, divorced from the merits of the ultimate
determination of equivalency, but rather on the applicability
of the equivalency criteria themselves. Third, equating the
doctrine to an equitable writ will generate needless
litigation over collateral issues (clean hands, for example)
11 Amicus believes the difference in pH between Petitioner’s
process and Respondent’s patent claim makes that true of this
case.
od The jury charge in this case (quoted at 52 F.3d 1561
(dissenting opinion of Judge Nies)) was conclusionary and
plainly inadequate, really nothing more than a summary
restatement of the triple identity test. A trial judge must fashion
the charge to the relevant circumstances of the particular case to
provide the jury adequate guidance for a substantiality
determination. See Lear Siegler, Inc. v. Sealy Mattress Co. of
Michigan, Inc., 873 F.2d. 1422, 1425-26 (Fed. Cir. 1989) ("a
jury must be separately directed to the proof of each Graver
Tank element").
12
that are part of traditional equity jurisprudence but usually
irrelevant to a patent suit. Fourth, and most importantly,
the standards of review by a Court of Appeals of a
an equitable writ. The Federal Circuit will be
future cases to adapt these standards to the criteria
enunciated by this Court as appropriate for equivalency
The application of the equivalence criteria to any case
requires careful control by a trial judge. Trial judges have
been accused, even by certain judges of the Federal
Circuit,!3 of translating a dislike of patent cases or a lack
of technical expertise into a predilection to pass off difficult
issues to the jury whenever possible. If this occurs it is
indefensible whatever one’s views of the role of the jury in
patent litigation. Patent litigation has sprouted like the
leaves of the green bay tree. Restricting the doctrine of
equivalents as amicus proposes may not stem this growth,
but it should eliminate one excess that defies the regime
established by Congress for promotion of the useful arts.
Under either an equitable threshold standard or the ordinary
rules for summary judgment, JMOL, and jury charges, the
trial judge must keep the doctrine of equivalents in its
proper, limited place.
13 See, e.g., 62 F.3d at 1538, 1542 (Plager J., dissenting).
13
CONCLUSION
The Court should limit use of infringement by equivalents
to cases of “invention” by copying, and set out the criteria
for application of the doctrine of equivalents in that limited
class of cases. Under the standards proposed by amicus,
the judgment of the Court of Appeals should be reversed.
April 15, 1996
RICHARD GRANT Lyon, ESQ.
Counsel of Record
GIBSON, D & CRUTCHER
1717 Main Street
Suite 5400
Dallas, Texas 75201
(214) 698-3100
Attorney for Amicus Curiae
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.